-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: Jim Greenwood
Touring CA Biotech Companies with Governor Howard Dean, MD
Last summer, BIO joined with former Vermont Governor Howard Dean to advocate for biosimilar legislation that protects patient safety and promotes necessary incentives for continued innovation of biologics. The Governor, a trained physician, is a passionate supporter of the value of biotech products in treating disease and reducing healthcare costs. To further familiarize him with the diversity of our member companies, I accompanied Governor Dean for a two-day tour of California biotech companies earlier this Read More >
Meeting India’s Biotech Community
Biotechnology is a global enterprise. The United States continues to play the dominant role but European and Asian nations are continually expanding their capabilities. In preparation for BIO’s first ever partnering meeting in India in September 2010, I am travelling the subcontinent to promote the event and to assess the country’s biotech capabilities and needs. On November 4th in Mumbai, I visited Reliance Life Sciences which represents a huge investment in biotech from one of Read More >
Meeting India’s Biotech Community
Biotechnology is a global enterprise. The United States continues to play the dominant role but European and Asian nations are continually expanding their capabilities. In preparation for BIO’s first ever partnering meeting in India in September 2010, I am travelling the subcontinent to promote the event and to assess the country’s biotech capabilities and needs. On November 4th in Mumbai, I visited Reliance Life Sciences which represents a huge investment in biotech from one of Read More >
Encouraging Louisiana to Partner with BIO
Louisiana is one of just a few states that do not yet have a BIO affiliate. I was invited to speak to community leaders in New Orleans by Jim McNamara, a local real estate investor who is presently the Secretary of the Board of the New Orleans BioInnovation Center, a Member of the Greater New Orleans Biosciences Economic Development District and a Commissioner of the Downtown Development District of New Orleans. Jim believes biotechnology can Read More >
Protection against Seasonal Flu
Today, BIO offered seasonal flu vaccines to all employees, many of whom joined me in getting one. While getting vaccinated against seasonal flu is important, it will not protect us from H1N1 flu so we were advised to get vaccinated against that once it is available. BIO member companies have played a major role in the development and distribution of both the seasonal influenza vaccination and the H1N1 vaccination. Five BIO member companies are at Read More >




